Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Colorcon
Dow
McKesson
Johnson and Johnson

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Litigation Details for AstraZeneca LP v. Prinston Pharmaceutical Inc. (D. Del. 2015)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

AstraZeneca LP v. Prinston Pharmaceutical Inc. (D. Del. 2015)

Docket   Start Trial Date Filed 2015-11-16
Court District Court, D. Delaware Date Terminated
Cause 35:145 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand Defendant Referred To
Parties ASTRAZENECA AB; ASTRAZENECA LP; ASTRAZENECA PHARMACEUTICALS LP; ASTRAZENECA UK LIMITED; PRINSTON PHARMACEUTICAL INC.
Patents 6,251,910; 6,525,060; 7,250,419; 7,265,124; 8,425,934
Attorneys Benjamin A. Smyth; Daniel M. Silver; Jill K. MacAlpine; Kelly E. Farnan; Mark J. Feldstein; Michael P. Kelly; Ryan P. O'Quinn
Link to Docket External link to docket
Small Molecule Drugs cited in AstraZeneca LP v. Prinston Pharmaceutical Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for AstraZeneca LP v. Prinston Pharmaceutical Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-11-16 1 AstraZeneca’s U.S. Patent Nos. 6,251,910 (“the ’910 patent”), 6,525,060 (“the ’060 patent”), 7,250,419 (“… This is an action for patent infringement arising under the patent laws of the United States, … 2 of 12 PageID #: 2 ’124 patent”), and 8,425,934 (“the ’934 patent”) that are listed in the Approved… PATENTS-IN-SUIT 23. On June 26, 2001, the U.S. Patent and Trademark Office… 6 patent are valid and enforceable. AstraZeneca UK Limited is the owner of the ’910 patent by assignment External link to document
2015-11-16 3 Date of Expiration of Patent: 6,251,910 (July 15, 2018) … Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …Received Notice: 10/03/2015. Date of Expiration of Patent: SEE ANDA.Thirty Month Stay Deadline: 1/20/2019… ) SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG…16 November 2015 1:15-cv-01057 830 Patent Defendant District Court, D. External link to document
2015-11-16 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,251,910; 6,525,060; 7,250,419…16 November 2015 1:15-cv-01057 830 Patent Defendant District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Merck
Mallinckrodt
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.